DOI:
10.1055/s-00034922
Arthritis und Rheuma
LinksClose Window
References
Maksymowych WP. et al.
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondyli-tis.
Arthritis Rheum 2002;
46 (03) 766-773.
We do not assume any responsibility for the contents of the web pages of other providers.